US policy for lower drug prices could extend waiting times for European patients
TL;DR
AI-generated
US plans to lower drug prices may lead pharmaceutical companies to delay the introduction of new medications in Europe. A study in "The Lancet" suggests this could result in longer waiting times for European patients as companies seek to limit potential losses in the US market.
Source: euronews.com
Discussion
Log in to join the discussion.
No comments yet. Be the first!